Skip to main content

Animations

MJFF Publications

3451 - 3460 of 6516 Results
Title
Year
  • Year
  • 2025
  • 2024
  • 2025
  • 2023
  • 2024
  • 2025
  • 2023
  • 2025
  • 2024
  • 2025
  • Summary Details
    OPEN
    Title: Motor and nonmotor features of p.A53T alpha-synuclein PD vs idiopathic PD: longitudinal data from the PPMI study
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-024-12836-w
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.adq3539
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Advice for translational neuroscience: move deliberately and build things
    Journal Name: Bioelectronic Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s42234-025-00165-w
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Impact of deep brain stimulation on gait in Parkinson disease: A kinematic study
    Journal Name: Gait & Posture
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.gaitpost.2023.12.002
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Rapid 2D 23Na MRI of the calf using a denoising convolutional neural network
    Journal Name: Magnetic Resonance Imaging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.mri.2024.04.027
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Current safety recommendations for handling mouse and human αsynuclein pre-formed fibrils
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2025.106820
    Citation Count: 5
  • Summary Details
    OPEN
    Title: DOPA pheomelanin is increased in nigral neuromelanin of Parkinson’s disease
    Journal Name: Progress in Neurobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.pneurobio.2023.102414
    Citation Count: 18
  • Summary Details
    OPEN
    Title: The effect of polygenic risk score on PD risk and phenotype in LRRK2 G2019S and GBA1 carriers
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x241310722
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Psychotropic medication usage in sporadic versus genetic behavioral‐variant frontotemporal dementia
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.14448
    Citation Count: 1
  • Summary Details
    OPEN
    Title: α-Synuclein Seed Amplification Assay Amplification Parameters and the Risk of Progression in Prodromal Parkinson Disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000210279
    Citation Count: 24
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.